Patient perspectives of value of delayed disease progression on imaging (imaging PFS). A treatment trade-off experiment

Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review

(2020) Lisa Belin et al.   BRITISH JOURNAL OF CANCER

A novel, more reliable approach to use of progression-free survival as a predictor of gain in overall survival: The Ottawa PFS Predictive Model

(2020) David J. Stewart et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Financial interests of patient organisations contributing to technology assessment at England’s National Institute for Health and Care Excellence: policy review

(2019) Kate L Mandeville et al.   BMJ-British Medical Journal

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

(2019) Krishnansu S. Tewari et al.   JOURNAL OF CLINICAL ONCOLOGY

The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer

(2019) Michael J. Raphael et al.   JAMA Oncology

Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology

(2018) Bruno Kovic et al.   JAMA Internal Medicine

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

(2016) Lowell E. Schnipper et al.   JOURNAL OF CLINICAL ONCOLOGY

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

(2015) N. I. Cherny et al.   ANNALS OF ONCOLOGY

Progression-free survival as an end-point in solid tumours – Perspectives from clinical trials and clinical practice

(2014) Andrew G. Robinson et al.   EUROPEAN JOURNAL OF CANCER

Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials

(2012) C. Giessen et al.   CLINICAL CANCER RESEARCH